Free Trial

Kyverna Therapeutics (KYTX) SEC Filings & 10K Form

Kyverna Therapeutics logo
$2.12 -0.02 (-0.70%)
As of 10:31 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Kyverna Therapeutics SEC Filings

DateFilerForm TypeView
04/15/2025
11:15 PM
Kyverna Therapeutics (Filer)
Form EFFECT
04/15/2025
4:40 PM
Kyverna Therapeutics (Issuer)
Walker Karen Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
4:42 PM
Jones Ryan Alexander (Reporting)
Kyverna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
4:42 PM
Biddle Warner Weston (Reporting)
Kyverna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
3:38 PM
Kyverna Therapeutics (Filer)
Form 424B5
04/14/2025
3:07 PM
Kyverna Therapeutics (Filer)
Form ARS
04/14/2025
3:03 PM
Kyverna Therapeutics (Filer)
Form DEF 14A
04/14/2025
3:05 PM
Kyverna Therapeutics (Filer)
Form DEFA14A
03/27/2025
3:53 PM
Kyverna Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/27/2025
3:58 PM
Kyverna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2025
3:48 PM
Kyverna Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/19/2025
4:55 PM
Kyverna Therapeutics (Issuer)
Shaw Christi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
7:00 PM
GEHCHAN NAJI (Reporting)
Kyverna Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/24/2025
7:05 PM
GEHCHAN NAJI (Reporting)
Kyverna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
6:35 AM
Kyverna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
3:57 PM
Kyverna Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/26/2024
3:40 PM
Kyverna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:16 PM
Kyverna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
6:23 AM
Kyverna Therapeutics (Subject)
Westlake BioPartners Fund I, L.P. (Filed by)
Form SC 13G
10/24/2024
5:02 AM
Aktar Mert (Reporting)
Kyverna Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/24/2024
5:05 AM
Aktar Mert (Reporting)
Kyverna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
7:00 AM
Kyverna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
11:36 AM
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Kyverna Therapeutics (Subject)
Form SC 13G
09/18/2024
8:11 PM
Kyverna Therapeutics (Issuer)
Shaw Christi (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/18/2024
8:15 PM
Biddle Warner Weston (Reporting)
Kyverna Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/18/2024
8:16 PM
Kyverna Therapeutics (Issuer)
Shaw Christi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
8:18 PM
Biddle Warner Weston (Reporting)
Kyverna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:05 AM
Kyverna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
3:18 PM
Kyverna Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
3:11 PM
Kyverna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
3:11 PM
Kyverna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
5:12 AM
Kyverna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
5:56 PM
Kyverna Therapeutics (Issuer)
Walker Karen Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
3:33 PM
Jones Ryan Alexander (Reporting)
Kyverna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:KYTX) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners